PMID: 9178387Jun 1, 1997Paper

High dose naloxone does not improve cerebral or myocardial blood flow during cardiopulmonary resuscitation in pigs

Resuscitation
H W GervaisW Dick

Abstract

In a prospective, randomized, placebo-controlled, double-blind trial we tested the hypothesis that naloxone given during cardiopulmonary resuscitation (CPR) enhances cerebral and myocardial blood flow. Twenty-one anesthetized, normoventilated pigs were instrumented for measurements of right atrial and aortic pressures, and regional organ blood flow (radiolabeled microspheres). After 5 min of untreated fibrillatory arrest, CPR was commenced using a pneumatic chest compressor/ventilator. With onset of CPR, an i.v. bolus of 40 micrograms/kg b.w. of epinephrine was given, followed by an infusion of 0.4 micrograms/kg per min. After 5 min of CPR, either naloxone, 10 mg/kg b.w. (group N, n = 11) or normal saline (group S, n = 10) was given i.v. Prior to, and after 1, 15, and 30 min of CPR, hemodynamic and blood flow measurements were obtained. After 30 min of CPR, mean arterial pressure was significantly higher in group N (26 +/- 5 vs. 13 +/- 3 mmHg, P < 0.05). Groups did not differ with respect to myocardial perfusion pressure or arterial blood gases at any time during the observation period. Regional brain and heart blood flows were not different between N and S at any point of measurement. We conclude that high-dose naloxone does n...Continue Reading

References

Jul 1, 1977·Progress in Cardiovascular Diseases·M A HeymannA M Rudolph
Jan 1, 1991·Annals of Emergency Medicine·M G Goetting, N A Paradis
Feb 1, 1985·Proceedings of the Society for Experimental Biology and Medicine·R B LechnerD G Reynolds
Jul 1, 1986·Resuscitation·W G BarsanS A Syverud
Jul 1, 1988·Journal of Neurosurgery·W G ObanaM C Nishimura
Mar 1, 1988·Pharmacopsychiatry·A Czlonkowska, B Cyrta
Apr 1, 1987·Anesthesia and Analgesia·H Bretschneider
Mar 1, 1987·Neurosurgery·S S Haghighi, B Chehrazi
Sep 1, 1987·The American Journal of Emergency Medicine·P J FoleyM A Elchisak
Mar 1, 1986·Clinical Endocrinology·P M BoulouxG M Besser
May 1, 1986·Stroke; a Journal of Cerebral Circulation·H P AdamsM Goldberg
Oct 1, 1985·Neurosurgery·J W PhillisJ K Towner
Sep 10, 1971·Science·S I RapoportI Klatzo
Jul 1, 1984·Stroke; a Journal of Cerebral Circulation·R J FallisR A Lobo
Sep 7, 1984·JAMA : the Journal of the American Medical Association·A I Faden
Nov 1, 1982·Pharmacology, Biochemistry, and Behavior·A J KastinR D Olson
Aug 1, 1982·British Journal of Pharmacology·O FagbemiL Szekeres
Aug 1, 1984·Neurosurgery·D M TurnerD J Boarini
Sep 1, 1983·Stroke; a Journal of Cerebral Circulation·R Y ChenS Chien
Nov 1, 1983·Neurology·J R CutlerR P Simon
Jun 1, 1984·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T SasakiH C Coester
Jun 17, 1983·European Journal of Pharmacology·J L Bergey, M E Beil

❮ Previous
Next ❯

Citations

Aug 3, 2012·Journal of Veterinary Emergency and Critical Care·Elizabeth A RozanskiUNKNOWN RECOVER Advanced Life Support Domain Worksheet Authors

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.